Search -

Displaying 1 - 20 of 29

Sort: Relevancy | Date

Presentation Miami Valves 2025

Initial Experience with the Acurate Neo2 TAVR in the Dominican Republic

Presenter: Karla Marie Garcia Almonte

January 30, 2025

Presentation Miami Valves 2025

Selected Case of CE Approved TAVR Valve: Acurate Neo2

Presenter: Fábio S. Brito Jr.

January 30, 2025

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

TCT 928: Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up

Presenter: Ignacio Amat-Santos

October 28, 2024

Presentation TCT 2023

TCT 261: Review of Short-term Outcomes of ACURATE neo2

Presenter: Akihiro Tobe

October 26, 2023

Presentation TCT 2023

ACURATE Neo2: Update From the ACURATE IDE and Worldwide Studies

Presenter: Pradeep Yadav

October 25, 2023

Presentation TCT 2023

TCT 474: ACURATE neo2 Implantation Without Balloon Predilatation (Direct ACURATE neo2)

Presenter: Ahmed Elkoumy

October 25, 2023

Presentation TCT 2023

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Presenter: Francesco Giannini

October 25, 2023

Presentation TCT 2022

TCT 610: BASILICA procedure prior to valve-in-valve TAVR in an ACURATE Neo TAVR prosthesis

Presenter: Anna Damlin

September 18, 2022

Presentation TCT 2022

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

Presenter: Jonas Lanz

September 17, 2022

Presentation TVT 2022

ACURATE neo2: design features and clinical data

Presenter: Azeem Latib

June 09, 2022

Presentation TVT 2022

Acurate Neo2: Update From the ACURATE IDE and Related Studies

Presenter: Michael J. Reardon

June 08, 2022

Presentation TVT 2022

Transcatheter Aortic Valve Replacement With the Self-Expanding ACURATE neo2: Hemodynamic Performance and Clinical Outcomes

Presenter: Andrea Scotti

June 08, 2022

Presentation TCT Abstracts Posters 2019

Comparison of Clinical Events of Two New-Generation Supra-annular Self-expanding Transcatheter Aortic Valves (Allegra versus ACURATE neo).

Presenter: Ariana Gonzálvez-García

September 29, 2019

Presentation TCT 2019

Mitigating a Devastating Outcome: SENTINEL CPS in TAVR

Presenter: Kendra Grubb

September 27, 2019

Presentation TCT 2019

Real-World Experience of the LOTUS Edge Valve

Presenter: Hemal Gada

September 27, 2019

Presentation TCT 2019

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

Presenter: Thomas Pilgrim

September 27, 2019

Presentation TCT 2019

ACURATE neo: Features and Benefits for Optimized TAVR

Presenter: Helge Möllmann

September 27, 2019

Presentation TCT 2019

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Presenter: Jonas Lanz

September 27, 2019

Presentation TCT 2019

Program Update: The ACURATE NEO TAVR System

Presenter: Michael Reardon

September 27, 2019

Advertisement

Initial Experience with the Acurate Neo2 TAVR in the Dominican Republic

Selected Case of CE Approved TAVR Valve: Acurate Neo2

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

TCT 928: Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up

TCT 261: Review of Short-term Outcomes of ACURATE neo2

ACURATE Neo2: Update From the ACURATE IDE and Worldwide Studies

TCT 474: ACURATE neo2 Implantation Without Balloon Predilatation (Direct ACURATE neo2)

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

TCT 610: BASILICA procedure prior to valve-in-valve TAVR in an ACURATE Neo TAVR prosthesis

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

ACURATE neo2: design features and clinical data

Acurate Neo2: Update From the ACURATE IDE and Related Studies

Transcatheter Aortic Valve Replacement With the Self-Expanding ACURATE neo2: Hemodynamic Performance and Clinical Outcomes

Comparison of Clinical Events of Two New-Generation Supra-annular Self-expanding Transcatheter Aortic Valves (Allegra versus ACURATE neo).

Mitigating a Devastating Outcome: SENTINEL CPS in TAVR

Real-World Experience of the LOTUS Edge Valve

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

ACURATE neo: Features and Benefits for Optimized TAVR

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Program Update: The ACURATE NEO TAVR System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content